doi: 10.3389/fimmu.2025.1635071 Received 25 May 2025 Accepted 26 June 2025 Published 06 August 2025 Volume 16 - 2025 Edited by Subhadeep Roy, Mesra, India Reviewed by Amit Kumar, Albert Einstein College of Medicine, United States Sapna Jain, Translational Health Science and Technology Institute (THSTI), India Updates Copyright 2025 Morsi, Hathout, AboShabaan, Emam, El-khadragy, Abdel Moneim, El-Garawani and Abu Quora
Market and Quality Risks Grey market and compounded peptide products can suffer from variable potency, contamination, or mislabeling, and FDA warning actions illustrate enforcement against vendors marketing unapproved BPC157 formulations
Acta Crystallogr
Related reading: Peptide and Muscle Recovery Research Delivery Format: Oral Strips, Capsules, and Injections Peptide delivery format is an important research and formulation topic